Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Emin, Tamer Elkiran"'
Autor:
Feyza Firat Atay, Fatma Hilal Yagin, Cemil Colak, Emin Tamer Elkiran, Nasrin Mansuri, Fuzail Ahmad, Luca Paolo Ardigò
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundDifferentiated thyroid cancer (DTC) is the most prevalent endocrine malignancy with a recurrence rate of about 20%, necessitating better predictive methods for patient management. This study aims to create a relational classification model
Externí odkaz:
https://doaj.org/article/ecccc2b10fe64354831493486686b4b9
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss , Pp 100366- (2021)
Sunitinib malate is a multitargeted oral tyrosine kinase inhibitor (TKI) which is used in treatment of metastatic renal cell carcinoma with side effects such as diarrhea, mucositis, asthenia and myelosuppression. Serious toxicity associated with suni
Externí odkaz:
https://doaj.org/article/3953ac4aca43401589d2db31c9bedc7c
Autor:
Kemal Ekici, Oztun Temelli, Ayse Fatma Eraslan, Simay Gurocak, Nihal Kaplan Bozdag, Emin Tamer Elkiran, Ersoy Kekilli, Ahmet Kizilay
Publikováno v:
Medicine Science, Vol 5, Iss 4, Pp 928-32 (2016)
Our aim was to determine the treatment outcomes and the prognostic factors affecting local control in early stage glottic carcinoma (ESGC) treated with definitive radiotherapy (RT). Between April 2003 and May 2015, 76 patients with ESGC were treated
Externí odkaz:
https://doaj.org/article/3a0870c8cd0543b380627b2d5231872b
Publikováno v:
Volume: 17, Issue: 3 467-474
Harran Üniversitesi Tıp Fakültesi Dergisi
Harran Üniversitesi Tıp Fakültesi Dergisi
Background: The purpose of this descriptive study is to determine the perception of ilness and quality of life in patients with cancer.Materials and Methods: The sample of the study consisted of 151 cancer patients who were inpatient and outpatient i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0c0fecae38dd91b3ee37272b8b48fe
https://doi.org/10.35440/hutfd.810484
https://doi.org/10.35440/hutfd.810484
Autor:
Hüseyin Öztürk, Aydin Ciltas, Faysal Dane, M. Ekenel, Mehmet Artac, Ali Gökyer, Metin Ozkan, Irfan Cicin, Ahmet Alacacioğlu, Mehmet Aliustaoğlu, Havva Yesil Cinkir, Saadettin Kilickap, Birkan Aver, Haci Mehmet Turk, Abdurrahman Işikdoğan, Dogan Uncu, Erdem Cubukcu, Ilhan Oztop, Emin Tamer Elkiran, Berna Öksüzoğlu, Feyyaz Ozdemir
Publikováno v:
Journal of Oncological Sciences. 6:87-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::366ba5a3cf8402aa0fdff1db7e788fb3
https://doi.org/10.37047/jos.2020-75080
https://doi.org/10.37047/jos.2020-75080
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss, Pp 100366-(2021)
Sunitinib malate is a multitargeted oral tyrosine kinase inhibitor (TKI) which is used in treatment of metastatic renal cell carcinoma with side effects such as diarrhea, mucositis, asthenia and myelosuppression. Serious toxicity associated with suni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::844545181b9cc31ebd327c55438edb11
https://pubmed.ncbi.nlm.nih.gov/33812180
https://pubmed.ncbi.nlm.nih.gov/33812180
Autor:
Irfan Cicin, Mehmet Artac, Feyyaz Ozdemir, Metin Ozkan, Mustafa Benekli, Nezih Meydan, Sadettin Kilickap, Alper Sevinc, Abdurrahman Isikdogan, Faysal Dane, Mehmet Aliustaoglu, Berna Oksuzoglu, Mahmut Gumus, Emin Tamer Elkiran, Ozgur Ozyilkan
Objective Cytokines have been the mainstay of treatment in metastatic renal cell cancer (mRCC) for decades before the introduction of tyrosine kinase inhibitors (TKIs), which dramatically changed the therapeutic landscape in these patients. This obse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3237934761fbe92e804509ecf1df16b7
https://avesis.erciyes.edu.tr/publication/details/761eac20-9e0e-4edb-92dc-e3cf38ba25d0/oai
https://avesis.erciyes.edu.tr/publication/details/761eac20-9e0e-4edb-92dc-e3cf38ba25d0/oai
Autor:
Zeynep, Oruc, Muhammet Ali, Kaplan, Caglayan, Geredeli, Nilgun, Yildirim Sari, Ersin, Ozaslan, Aydin, Aytekin, Emin, Tamer Elkiran, Sinan, Koca, Mutlu, Dogan, Nedim, Turan, Ozlem, Yuce, Alper, Sevinc, Ozlem, Ercelep, Abdurrahman, Isikdogan
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(5)
This study aimed to analyze prognostic factors for survival and the reliability and the effectiveness of eribulin therapy in metastatic breast cancer (MBC) patients.A total of 80 patients treated with eribulin in 12 medical oncology centers in Turkey
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::761ad2d109333888005c7a067ccb5b7f
https://pubmed.ncbi.nlm.nih.gov/31786850
https://pubmed.ncbi.nlm.nih.gov/31786850
Autor:
Muhammet, Ali Kaplan, Zeynep, Oruc, Mahmut, Gumus, Sukru, Ozaydın, Emin Tamer, Elkiran, Nur Sener, Dinc, Abdullah, Sakin, Veli, Berk, Tulay, Akman, Aydin, Aytekin, Dogan, Yazilitas, Faysal, Dane, Goksen Inanc, Imamoglu, Erdem, Cubukcu, Abdurrahman, Isikdogan
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(3)
To analyze the reliability and the effectiveness of chemotherapy and prognostic factors for survival in patients with HER2 (human epidermal growth receptor 2) negative early-stage breast cancer treated with adjuvant sequential anthracycline-based che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d10beeef5c4f59deaec510df04ec6d2
https://pubmed.ncbi.nlm.nih.gov/31424664
https://pubmed.ncbi.nlm.nih.gov/31424664
Autor:
Alper Sevinc, Erdem Cubukcu, Aziz Karaoglu, Berna Oksuzoglu, Metin Ozkan, Arife Ulas, Gamze Gokoz-Dogu, Emin Tamer Elkiran, Faysal Dane, Murat Koçer, Abdurrahman Isikdogan, Mukremin Uysal, Mehmet Aliustaoglu, Irfan Cicin, Mustafa Benekli, Ersin Ozaslan
Publikováno v:
Clin Appl Thromb Hemost .
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis
We compared the efficacy and safety of low-molecular-weight heparins (LMWHs) in patients with cancer who are at low risk of venous thromboembolism (VTE). Patients were treated by medical oncologists in Turkey at 15 sites, where they were enrolled and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da1fa2f9cdeb44a8bb1d48ddb00f64a6